What are the criteria for the success or failure of a biotech company? Is it remaining on Long Island? Growth? Successful acquisition by a larger corporation? Bob Franza notes that the ultimate fate of Protein Databases, Inc. was that it “ultimately got sold, and so it wasn’t a failure in that sense.” PDI’s president and CEO Steve Blose explains that after the company’s acquisition by Bio-Rad Laboratories in California, “we continued to commercialize the technology with faster scanners, better software, and to keep it in the market. It was a real help because they had an international distribution system. Our small company just didn’t have that.”